ACS Synthetic Biology · 2019 · 26 citations · 34 references
MedicineMedicinal ChemistryPharmacologyAntimicrobial PharmacologyDrug DiscoveryMolecular PharmacologyGastrointestinal PharmacologyIrritable Bowel SyndromeSerotonergic PharmacologyAssayLuciferase Reporter AssaysPharmacology Of Serotonergic AgentsSerotonergic AgonistsSerotonergic Drug DiscoverySerotonin 5-Ht4 Receptor AgonistsSerotonin AgonistsSerotonin Type 4 Receptor Agonists
The serotonin receptor 4b (5-HTR4b) is expressed throughout the gastrointestinal tract, and its agonists are used in the treatment of irritable bowel syndrome with constipation (IBS-C). Today, there are no rapid assays for the identification of 5-HTR4b agonists. Here, we developed a luciferase-based 5-HTR4b assay capable of assessing one compound per second with a 38-fold dynamic range and nM limit of detection for serotonin. We used the assay to screen more than 1000 natural products and anti-infection agents and identified five new 5-HTR4b ligands: hordenine, halofuginone, proflavine, ethacridine, and revaprazan. We demonstrate that hordenine (antibiofilm), halofuginone (antiparasitic), and revaprazan (gastric acid reducer) activate 5-HTR4b in human colon epithelial cells, leading to increased cell motility or wound healing. The 5-HTR4b assay can be used to screen larger pharmaceutical libraries to identify novel treatments for IBS-C. This work shows that antimicrobials interact not only with the gut microbiota, but also with the human host.
34
HMDB 4.0: the human metabolome database for 2018
David S. Wishart, Yannick Djoumbou-Feunang, Ana Marcu et al. · Nucleic Acids Research · 2017 · 3.6K citations · Full text
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Kendle M. Maslowski, Angélica T. Vieira, Aylwin Ng et al. · Nature · 2009 · 3.2K citations
Anna Gaulton, Anne Hersey, Michał Nowotka et al. · Nucleic Acids Research · 2016 · 2.4K citations · Full text